Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Cigarette smoke extract stimulates bronchial epithelial cells to undergo a SUMOylation turnover

BMC Pulmonary Medicine volume 20, Article number: 276 (2020) Cite this article

Abstract

Background

Chronic obstructive pulmonary disease (COPD) characterized by the airway and lung inflammation, is a leading cause of morbidity and mortality worldwide, especially among smokers over 40 years of age and individuals exposed to biomass smoke. Although the detailed mechanisms of this disease remain elusive, there is feasible evidence that protein posttranslational modifications (PTMs) may play a role in its pathoetiology. We thus conducted studies to dissect the effect of cigarette smoke extracts (CSE) on the change of SUMOylated substrates in human bronchial epithelial cells (HBEs).

Methods

Samples were collected in HBEs with or without 24 h of CSE insult and then subjected to Western-blot and LC-MS/MS analysis. Subsequently, bioinformatic tools were used to analyze the data. The effect of SUMOylation on cytochrome P450 1A1 (CYP1A1) was evaluated by flow cytometry.

Results

It was noted that CSE stimulated HBEs to undergo a SUMOylation turnover as evidenced by the changes of SUMOylated substrates and SUMOylation levels for a particular substrate. The SUMOylated proteins are relevant to the regulation of biological processes, molecular function and cellular components. Particularly, CSE stimulated a significant increase of SUMOylated CYP1A1, a critical enzyme involved in the induction of oxidative stress.

Conclusions

Our data provide a protein SUMOylation profile for better understanding of the mechanisms underlying COPD and support that smoking induces oxidative stress in HBEs, which may predispose to the development of COPD in clinical settings.

Peer Review reports

Background

Chronic obstructive pulmonary disease (COPD), which affects more than 10% of population over 40 years of age, is a leading cause of hospital admissions and is currently the third leading cause of death worldwide [1]. The basic characteristics of COPD are chronic bronchiolitis and emphysema. Patients who have chronic bronchiolitis show persistent inflammation, goblet cell hyperplasia, and mucin hyperexpression in the airway [2]. The process of inflammation in COPD is characterized by the increased infiltrated T cells, B cells, neutrophils, dendritic cells and macrophages along with the upregulation of proinflammatory cytokines, leading to the destruction of lung tissue coupled with a decline in pulmonary function [3,4,5]. Accumulated evidence shows that cigarette smoking is a key risk factor for COPD, and cigarette smoke extract (CSE), which contains more than 4000 different types of constituents, including many toxic oxidants, is capable of inducing oxidative stress in airway epithelial cells, and ultimately, damaging airway epithelial cells [6, 7].

Posttranslational modifications (PTMs) are a common and reversible regulatory modification that allows the cells being able to regulate the function of proteins in response to intra- and extracellular signals. SUMOylation, one of the evolutionarily conserved reversible PTMs, is featured by the covalent attachment of the small ubiquitin-like modifier (SUMO) to its substrate proteins. In general, SUMO conjugates to its substrates involving an activating (E1) enzyme (a heterodimer known as SAE1/SAE2), a conjugating (E2) enzyme (Ubc9) that form thioesters (S) with the modifiers, and an E3 ligase [8, 9]. Moreover, as a reversible modification, SUMO can be removed from the target proteins by SENPs (SENP1–7), which called de-SUMOylation. SUMOylation is employed by almost all eukaryotes to regulate many cellular processes such as gene expression, genome stability, DNA damage repair, RNA processing, cell cycle progression and quality control of newly synthesized proteins [8, 10].

A growing number of studies have shown that the imbalance of SUMOylation and deSUMOylation is associated with the occurrence and progression of various diseases such as cancer, degenerative diseases, and diabetes [11,12,13]. Particularly, we have recently shown that SUMOylation is required to protect pancreatic beta cells against oxidative stress, partly by regulating the activity of nuclear factor-erythroid 2-related factor 2 (NRF2) to enhance reactive oxygen species (ROS) detoxification [14]. Given the role of NRF2 in the pathogenesis of COPD, we thus hypothesize that SUMOylation is of great importance in the pathogenesis of COPD [15]. To address this issue, we created a profile of differentially SUMOylated proteins by LC-MS/MS analysis in human bronchial epithelial cells (HBEs) following CSE challenge. We characterized that CSE stimulated HBEs to undergo a SUMOylation turnover characterized by the changes of SUMOylation patterns of substrates or SUMOylation levels for a particular substrate, which are implicated in the regulation of biological processes, molecular function and cellular components. In particular, our study revealed that CSE significantly enhanced CYP1A1 SUMOylation, indicating that oxidative stress induced by smoking plays a critical role in HBE injury, which may contribute to the initiation and progression of COPD.

Methods

Cell culture and treatment

The human Bronchial epithelial cell (HBE) line was obtained from the Shanghai Institute of Cell Biology, Chinese Academy of Sciences (Shanghai, China) and maintained in Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco, Shanghai, China) with 10% fetal bovine serum (FBS, Hyclone, Rockford, IL, USA), 50 μg/mL penicillin, and 50 μg/mL streptomycin (Sigma, St Louis, MO, USA). The cultures were maintained in a humidified atmosphere of 5% CO2 at 37 °C. Once cells reached 70–80% confluence, 20% CSE was added into the culture medium, and an equal volume of PBS was applied as a control for 24 h.

Preparation of CSE

CSE was prepared as described previously [16]. Briefly, mainstream smoke from one cigarette (Jiangxi Industrial Co., Ltd., Nanchang, China) was bubbled through 10 ml of culture medium. After adjustment of the pH to 7.4, the CSE was sterile-filtered through a 0.22-μm filter (33-mm Millex GV; Merck Millipore, Billerica, MA). This solution was considered to be 100% CSE. CSE was standardized by measuring the absorbance at wavelength 320 nm, freshly prepared for each experiment, and diluted with culture medium supplemented with 10% FBS before use.

Co-immunoprecipitation

Co-immunoprecipitation was carried out to confirm that CSE challenged HBEs underwent a change in terms of total SUMOylation levels or patterns. HBEs with or without CSE treatment were lysed in 1X RIPA cell lysis buffer containing a protease inhibitor cocktail (Sigma, St Louis, MO, USA) and phosphatase inhibitors A and B (Sigma, St Louis, MO, USA) in the presence of 20 mmol/L N-ethylmaleimide (NEM, Sigma, St Louis, MO, USA). The protein concentration was measured using the Bradford protein assay according to the manufacturer’s instructions (Boster Biological Technology co. ltd, Pleasanton, CA, USA). Endogenous SUMO1 and their associated substrates were then immunoprecipitated using a SUMO1 antibody (Cell Signaling, Danvers, MA) as reported [14], and the resulting precipitants were subjected to quantitative Western blot analysis as described below.

Sample collection and LC-MS/MS

Two independent samples of HBEs were harvested following 24 h of CSE insult and then subjected to LC-MS/MS analysis (PTM-Biolabs Co. Ltd., Hangzhou, China). The corresponding cells treated with vehicle were served as controls. Briefly, the SUMO-1 antibody affinity enrichment columns (Acclaim PepMap 100, Thermo Scientific) were employed to pull-down the SUMOylated proteins, followed by a label-free proteomic analysis to quantify SUMO1-cojugated lysine residues. Each sample was undergone three parallel LC-MS/MS analyses to obtain accurate quantification results.

Bioinformatics analysis

Gene Ontology (GO) annotation proteome derived from the UniProt-GOA database (http://www.ebi.ac.uk/GOA/) was employed for proteomic data analysis. Briefly, the identified protein ID was converted into UniProt ID and then mapped to GO IDs. If some of the identified proteins were not annotated by the UniProt-GOA database, the InterProScan software would be used to annotate protein’s GO properties based on protein sequence alignment method. The proteins were then classified by Gene Ontology annotation based on three categories: biological process, cellular component and molecular function. Kyoto Encyclopedia of Genes and Genomes (KEGG) database (http://www.genome.jp/kegg/) was next used to annotate protein pathway. Firstly, the KEGG online service tool, KAAS, was used to annotate the description of protein function in the KEGG database, and the annotated results were mapped to the KEGG pathway database using the KEGG online service tool, KEGG mapper. For each category, a two-tailed Fisher’s exact test was employed to test the enrichment of the differentially pulled down proteins against all identified proteins. Corrected P value< 0.05 was considered significant when performing the bioinformatic analysis. The wolfpsort software was used to predict subcellular localization for a particular identified protein.

Western blot analysis

The above prepared cell lysates or immunoprecipitates were separated on 10% (vol/vol) polyacrylamide gels and transferred onto PVDF membranes. The lysates and imminoprecipitates were probed with primary antibodies, including SUMO1, SUMO2/3 (Cell Signaling, Danvers, MA, USA), SUMO-specific protease 3 (SENP3), SUMO-specific protease 7 (SENP7) and beta-actin (Santa Cruz, Delaware, California, USA), and UBC9 (Cell Signaling, Danvers, MA, USA) for quantitative Western blot analysis, respectively, to confirm that the CSE insulted HBEs underwent a change in terms of total SUMOylation levels or patterns [14]. Similarly, to verify that CYP1A1 was SUMOylated by SUMO1, the above precipitates were probed with a CYP1A1 antibody (13241–1-AP) (Proteintech Group, Inc., Wuhan, China) and the reactive bands were developed using the established techniques [17]. Briefly, the membranes were incubated with an indicated primary antibody at 4 °C overnight. After washes with TBST (0.5% Tween) five times, the membranes were probed with an appropriate HRP-conjugated secondary antibody for 1 h, and the reactive bands were visualized using the ECL reagents (Servicebio, Wuhan, China) as instructed. Quantitative analysis of relative intensity of each band was conducted using the Image J software and β-actin was used for normalization.

CYP1A1 enzymatic activity assay

CYP1A1 enzymatic activity was measured in HBEs using a P450-Glo CYP1A1 Assay kit (Promega, Madison, WI, USA). All assays were performed in 96-well white-walled plates with clear bottoms (Greiner Bio-One, Kremsmünster, Austria) using the method as described by the manufacturer. The assay was performed on cells at 70–90% confluence.

Measurement of ROS

Measurement of reactive oxygen species (ROS) was carried out using a ROS assay kit (Beyotime, Shanghai, China) as previously described [18]. The cells were seeded at a density of 2.5 × 105 cells/well in 6-well culture plates in a final volume of 2 mL of DMEM with 1% FBS and were grown to ~ 70 to 80% confluency. Freshly prepared CSE was added, and the cells were incubated for 24 h, washed 3 times with prewarmed PBS, resuspended in 1 mL of PBS, and incubated with or without DCFH-DA (10 μM) for 30 min. The cells were washed and resuspended in PBS, and flow cytometric analysis was performed using a BD LSR flow cytometer (BD Biosciences, San Jose, CA, USA).

Apoptosis analysis

HBE apoptosis was analyzed using a PE Annexin V Apoptosis Detection Kit (BD Pharmingen, NA, USA) following the manufacturer’s instructions. The antioxidant Tempol (1 mM, Sigma-Aldrich) was added to rescue the injury induced by CSE treatment. The cells were treated and processed as described above, followed by addition of 5 uL PE-Annexin V and 5 uL 7-AAD solution to each well. After incubation at room temperature in the dark for 15 min, the cells were analyzed under a BD LSR flow cytometer (BD Biosciences, San Jose, CA, USA) as instructed.

Statistical analysis

All the experiments were conducted with at least three independent replications, except for the LC-MS/MS analysis, in which only two independent samples were used. Data are expressed as the mean ± SEM. All statistical analyses were carried out using GraphPad Prism 5.0 software (GraphPad Software Inc., San Diego, CA, USA). Data were analyzed using the Student’s t-test. A P value ≤0.05 was considered statistically significant.

Results

CSE induces HBEs to undergo a SUMOylation turnover

To demonstrate the effect of cigarette smoking on the changes of SUMOylated proteins in HBEs, we examined the expression of SUMO proteins and SUMOylation associated enzymes following CSE stimulation. To this end, we first sought to optimize the CSE dose and exposure time by serial of dilution assays. It was noted that CSE induced a significant increase in terms of SUMO1 expression following 20% CSE exposure for 12 h, and lasted up to 48 h (Supplementary Fig. 1). Furthermore, HBEs underwent apoptosis following 24 h of 20% CSE treatment (Supplementary Fig. 2), and a dose-dependent induction of SUMO1 expression was noted, but it became absent once CSE concentration reached above 20%. We thus selected 20% CSE and 24 h of exposure time for our experimental purpose.

Interestingly, Western blot analysis of HBE lysates found that CSE induced significantly higher levels of SUMO1 rather than SUMO2/3 expressions (Fig. 1a). Similarly, CSE challenge dramatically increased the expression of Ubc9, the only conjugating enzyme required for SUMOylation in HBEs (Fig. 1b), but no perceptible change was detected for the expression of SENP3 and SENP7, the two enzymes necessary for deSUMOylation (Fig. 1c). The remarkable up-regulation of SUMO1 and Ubc9 prompted us to check the SUMOylation patterns by SUMO1. In consistent with our observation, Western blot analysis of immunoprecipitates pulled down by a polyclonal SUMO-1 antibody revealed that CSE insult rendered HBEs to undergo the changes of SUMOylation patterns of its substrates and SUMOylation levels for a particular substrate (Fig. 1d).

Fig. 1
figure 1

CSE selectively induces increased expression of SUMO1 and Ubc9. HBEs challenged with CSE manifested enhanced SUMO1 (a) and Ubc9 (b) expression, but without perceptible change for Senp3 and 7 (c). Left panel: Representative results for Western blot analysis; r ight panel: quantitative results derived from 3 independent replications. d Western blot results of Co-IP products, which indicated increased SUMOylation profile by SUMO1 following CSE insult in HBEs. **, P < 0.01; ***, P < 0.001

Full size image

Characterization of SUMOylated substrates in HBEs by LC- MS/MS

Next, we sought to conduct comparative proteomic analysis of SUMOylated substrates between CSE insulted and control HBEs. For this purpose, HBEs were treated with 20% CSE or control vehicle as described earlier. The harvested cells were then employed for immunoprecipitation of SUMOylated proteins using the SUMO-1 affinity columns, and the resulting products (two independent samples for each group) were subjected to LC-MS/MS analysis, and each sample were carried out with three replications, followed by database searching to identify protein identities (Fig. 2a). We assume that CSE stimulates HBEs to undergo a SUMOylation turnover (changes of SUMOylation patterns of its substrates and SUMOylation levels for a particular substrate), which may provide critical information to the understanding of COPD pathogenesis.

Fig. 2
figure 2

Strategy and results for comparative proteomics analysis of HBEs following CSE insult. a Experimental strategy and technical route for the quantitative proteomics analysis. In the LC-MS/MS analysis, two independent samples with or without CSE treatment were prepared. The proteins were digested with trypsin followed by co-immunoprecipitation using the SUMO-1 affinity columns. Each sample were undergone three parallel LC-MS/MS analyses to acquire quantitative proteomic data. b Venn diagram illustrating the overlap of identified proteins between control and CSE challenged HBEs. c A bar graphic figure showing 39 up-regulated proteins (2-fold changes) and 25 down-regulated proteins (2-fold changes). d A heatmap for the abundance of up-regulated (fold change ≥2) substrates. e A heatmap showing the abundance of the down-regulated (fold change ≤0.05) substrates

Full size image

A total of 1201 SUMO-1 substrate proteins were identified from the above analysis (Table 1). To acquire high-throughput quantitative results, the proteins with consistent fold changes in at least two of the three replications were included for the analysis, by which quantitative results were obtained from 847 SUMO-1 substrate proteins (Table 1). Among which, 299 were unique substrates for the untreated control cells, and 62 substrates were specific for the CSE challenged cells, while the rest of 800 proteins were shared by both CSE treated and untreated HBEs (Fig. 2b). A cut off was then set up, and in which, a quantitative ratio over 2.0 was considered as upregulated substrates, while a quantitative ratio below 0.5 was regarded as downregulated substrates. This cut off allowed us to identify 39 upregulated proteins and 25 downregulated proteins in CSE treated HBEs (Fig. 2c, Table 2 and Tables 3 and 4). A heatmap was finally generated to present the up- or downregulated substrates in CSE challenged HBEs as compared to the control cells (Fig. 2d and e). In conclusion, the LC-MS/MS data demonstrated that CSE treatment induced significant changes in terms of SUMOylated substrate profiles, which were consistent with our Western blot results (Fig. 1d).

Table 1 MS/MS identified summary
Full size table
Table 2 Differentially modified SUMO-protein summary
Full size table
Table 3 List of up-regulated proteins in CSE-treated HBEs
Full size table
Table 4 List of down-regulated proteins in CSE-treated HBEs
Full size table

Results for gene ontology analysis of SUMO1 substrates

The above characterized substrates were further examined by GO analysis and categorized according to their cellular localization. Of note, the most abundant proteins were derived from the nucleus (37%), followed by the cytoplasm (36%), mitochondria (10%), and extracellular region (6%) (Table 5). In addition to cellular localization, GO terms include Biological Process (BP), Cellular Component (CC) and Molecular Function (MF) for functional analysis. The top upregulated substrates through analysis of GO terms are implicated in cytoplasmic mRNA processing body, transition metal ion binding and regulation of gene expression, respectively (Fig. 3a). While the top downregulated substrates were involved in the regulation of nucleosome, sulfur compound binding and nucleosome assembly, respectively (Fig. 3b).

Table 5 The summary of subcellular location of regulated and identified sumo-1 modified proteins
Full size table
Fig. 3
figure 3

GO-based enrichment analysis of upregulated and downregulated proteins. In addition to cellular localization, the GO terms include Biological Process (BP), Cellular Component (CC) and Molecular Function (MF). a Analysis of upregulated proteins in BP, CC, and MF. b Analysis of downregulated proteins in BP, CC, and MF

Full size image

Results for KEGG pathway analysis of substrates

KEGG significant enrichment was then conducted to identify the biochemical metabolic pathways of differentially SUMOylated substrates. KEGG analysis revealed 14 significant pathways with P < 0.05, including up-regulated pyrimidine metabolism, synthesis and degradation of ketone bodies, systemic lupus erythematosus (Fig. 4a), and downregulated citrate cycle (TCA cycle), carbon metabolism, and biosynthesis of amino acids (Fig. 4b). Particularly, the pathway relevant to the synthesis and degradation of ketone bodies was upregulated following CSE treatment. Recent studies have shown that ketone metabolism participates in the process of oxidative stress [19,20,21]. Ketogenic metabolism reduces oxidative stress after spinal cord injury in rats by inhibiting histone deacetylase (HDAC) [22], and a ketogenic diet and ketone salt supplementation can acutely and chronically enhance the expression of endogenous antioxidants and reduce oxidative stress in multiple tissues. Therefore, it is likely that the upregulated synthesis and degradation of ketone bodies could be a compensated effect resulted from CSE-induced oxidative stress.

Fig. 4
figure 4

Results for the KEGG pathway-based enrichment analysis. a Summary of upregulated biochemical metabolic pathways. b Summary of downregulated biochemical metabolic pathways

Full size image

CSE enhances CYP1A1 SUMOylation to promote oxidative stress

Given that a well-balanced SUMOylation pattern is indispensable for cell viability and against oxidative stress [23], we further analyzed the proteomic data with focus for the substrates relevant to antioxidant capability. Cytochrome P450 1A1 (CYP1A1), a member of the cytochrome P450 superfamily of enzymes that can use an electron from NADPH to reduce O2, leading to the production of H2O2 and a superoxide anion radical [24], was selected for further analysis. It was noted that its SUMOylation levels were significantly increased following CSE challenge (Fig. 2d). To confirm this result, HBEs were challenged by CSE and then subjected to co-immunoprecipitation as described earlier, and the resulting precipitates were analyzed by Western blotting. Indeed, CYP1A1 is a substrate for SUMOylation, and CSE treatment significantly increased the levels of SUMOylated form of CYP1A1 (Fig. 5a, indicated by arrows). This result is consistent with published data that smoking induces CYP expression to increase oxidative stress [25].

Fig. 5
figure 5

CSE induces CYP1A1 SUMOylation to regulate its enzymatic activity and ROS accumulation in HBEs. a Co-Immunoprecipitation results showing increased SUMOylation levels for CYP1A1 in CSE insulted HBEs. The input and elution samples were used for Western blot analysis. The SUMOylated bands of CYP1A1 are indicated by arrows. b Enzymatic activity analysis of CYP1A1 in HBEs with or without CSE treatment. c ROS analysis of HBEs transfected with control-plasmid or SUMO1-plasmid followed by CSE treatment. All experiments were conducted with 3 independent replications. The data are represented as the mean ± SEM. *, P < 0.05; **, P < 0.01 ***; P < 0.001

Full size image

Next, we intended to demonstrate the effect of SUMOylation on CYP1A1 enzymatic activity. To this end, 7-ethoxyresorufin-O-deethylase (EROD) assays were conducted to measure CYP1A1 enzymatic activity. It was noted that CSE remarkably increased the enzymatic activity of CYP1A1 (Fig. 5b). More interestingly, once SUMO-1 was transfected into HBEs to enhance the SUMOylation of CYP1A1, CSE induced CYP1A1 activity was even higher (Fig. 5b) coupled with higher levels of ROS accumulation (Fig. 5c) and apoptosis (Supplementary Fig. 2). In addition, apoptosis can be rescued by treatment of antioxidant reagent Tempol (Supplementary Fig. 3). Taken together, our results demonstrate that CSE enhance CYP1A1 SUMOylation, thereby promoting oxidative stress and apoptosis in HBEs.

Discussion

Cigarette smoking is the most common risk factor for COPD by inducing inflammation and damage in the airway epithelial cells. Therefore, understanding of the mechanisms underlying epithelial injury could be important to screen potential targets for developing therapeutic drugs against COPD in clinical settings. There is compelling evidence that posttranslational protein modifications function as a cellular regulatory mechanism in response to various stressful stimuli [26,27,28]. Among which, SUMOylation, one of the reversible posttranslational modifications, has recently been noted to play a critical role in the regulation of cellular processes including gene transcription, protein localization, DNA repair and cell cycle progression [29, 30]. Importantly, a well-balanced SUMOylation in substrates is essential for normal cellular behaviors, and altered SUMOylation predisposes to the risk for developing a large number of diseases such as cancer, neurodegenerative disorders (e.g., Alzheimer’s, Parkinson’s, and Huntington’s disease), diabetes and so on [31,32,33,34,35,36]. However, the exact impact of SUMOylation on the regulation of airway inflammation and epithelial damage in smoking subjects remains almost completely unknown.

In the present report, we conducted studies in HBEs to assess the relationship between CSE insult and the changes of SUMOylation profile. Interestingly, CSE specifically induced the expression of SUMO1 and Ubc9 in HBEs, but without a significant impact on the expression of SUMO2/3, SENP3 and SENP7. Next, we employed CSE to stimulate HBEs followed by immunoprecipitation of SUMOylated substrates along with LC-MS/MS analysis to obtain the accurate quantification data on the changes of SUMOylated proteins. We found that CSE induced HBEs to undergo a SUMOylation turnover as manifested by the changes of SUMOylated substrates and SUMOylation levels for a particular substrate. Specifically, we identified 39 up-regulated and 25 down-regulated proteins in CSE stimulated HBEs. These proteins were then annotated and enriched into different pathways through the Gene Ontology and KEGG analysis, respectively. Interestingly, our data revealed that those substrates with upregulated SUMOylation levels were involved in cytoplasmic mRNA processing body, transition metal ion binding and gene expression, while those substrates relevant to nucleosome and sulfur compound binding were down-regulated. The KEGG analysis of quantified proteins further indicated that the substrates with enhanced SUMOylation were enriched in ketone and pyrimidine metabolism, while those with decreased SUMOylation were implicated in TCA cycle, carbon metabolism and biosynthesis of amino acids. There is feasible evidence that ketone metabolism is involved in the process of oxidative stress induction [19, 21], and therefore, upregulation of SUMOylated substrates relevant to ketone metabolism following CSE challenge could be associated with ROS accumulation along with the induction of oxidative stress.

Indeed, some of the identified substrate proteins were recognized to be involved in the induction of oxidative stress, which may serve as critical risk factors contributing to the development of COPD [37, 38]. Particularly, CYP1A1, a member of the cytochrome P450 superfamily, was identified with enhanced SUMOylation in HBEs following CSE stimulation. Previous studies suggest that CYP1A1 could enhance oxidative stress by generating excessive ROS [39, 40]. We first confirmed that CYP1A1 can be SUMOylated, and SUMOylation enhances its catalytic activity as evidenced by the increased EROD signal along with higher ROS accumulation. Collectively, our data support that CSE induce oxidative stress not only by inducing the expression of CYP1A1, but also by enhancing its SUMOylation to increase its functionality.

Previous studies from other groups and ours have demonstrated convincing evidence that SUMOylation provides protection for cells against oxidative stress [11, 41, 42]. For example, SUMOylation of Nrf2 promotes its transcriptional activity, thereby protecting pancreatic beta cells from oxidative stress through enhanced capacity for detoxification of ROS [14]. In sharp contrast, our current data support that enhanced SUMOylation of CYP1A1 promotes its enzymatic activity along with increased ROS accumulation following CSE challenge in HBEs. This discrepancy is likely caused by the cell type differences and pathological stimuli, as each type of cells manifest different types of proteins for SUMOylation following stimulation. In support of this notion, our proteomic data revealed that NRF2 was SUMOylated in the pancreatic beta cells following inflammatory cytokine stimulation [14], while we failed to detect SUMOylated NRF2 in HBEs after CSE insult, rather CYP1A was found to be SUMOylated. In general, as aforementioned, a well-balanced SUMOylation pattern and levels of substrate proteins are essential for the cell viability and functionality. As a result, the overall impact of SUMOylation on the regulation of oxidative stress in a particular cell type may depend on the specific pathological conditions encountered (e.g., CSE insult in airway epithelial cells).

Of note, there are also some shortcomings in our present study. Although we have predicted by bioinformatics tools that Lys267 and 487 (K267 and K487) could be the SUMOylation sites, we failed to provide direct experimental evidence that these two lysine residues are the actual SUMO-conjugating sites, which would be our focus in the future studies. Additionally, P62, (also named Sequestosome1) also manifested with enhanced SUMOylation in HBEs following CSE insult. There is evidence that the upregulation and/or reduced degradation of P62 are implicated in tumor formation, cancer progression, and induction of oxidative stress as well as resistance to chemotherapy [43, 44]. However, the impact of SUMOylated P62 on CSE-induced airway epithelial injury is yet to be addressed.

Conclusion

In summary, our investigation suggests that CSE induce oxidative stress in airway epithelial cells. CSE could promote the SUMOylation of CYP1A1, thereby enhancing ROS production to exacerbate oxidative stress. CSE also upregulates ketone metabolism to promote oxidative stress and to induce airway epithelial injury. Importantly, our study generated a protein SUMOylation profile, which could provide critical information for better understanding of the mechanisms underlying COPD.

Availability of data and materials

All data analyzed during this study are included in this article and its figures and tables. Additional data may be available from the corresponding author upon reasonable request.

Abbreviations

COPD:

Chronic obstructive pulmonary disease

CSE:

Cigarette smoke extract

HBEs:

Human bronchial epithelial cells

PTM:

Posttranslational modification

SUMO:

Small ubiquitin-like modifier

NRF2:

Nuclear factor-erythroid 2-related factor 2

SENP3:

SUMO-specific protease 3

SENP7:

SUMO-specific protease 7

EROD:

7-ethoxyresorufin-O-deethylase

CYP1A1:

Cytochrome P450 1A1

DMEM:

Dulbecco’s Modified Eagle’s Medium

GO:

Gene Ontology

KEGG:

Kyoto Encyclopedia of Genes and Genomes

ROS:

Reactive oxygen species

HDAC:

Histone deacetylase

References

  1. Gagnon P, Guenette JA, Langer D, Laviolette L, Mainguy V, Maltais F, Ribeiro F, Saey D. Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chronic Obstructive Pulmonary Dis. 2014;9:187–201.

    Google Scholar 

  2. Ramos FL, Krahnke JS, Kim V. Clinical issues of mucus accumulation in COPD. Int J Chronic Obstructive Pulmonary Dis. 2014;9:139–50.

    Google Scholar 

  3. Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27.

    Article  CAS  PubMed  Google Scholar 

  4. Barbu C, Iordache M, Man MG. Inflammation in COPD: pathogenesis, local and systemic effects. Romanian J Morphol Embryol = Revue roumaine de morphologie et embryologie. 2011;52(1):21–7.

    Google Scholar 

  5. Boukhenouna S, Wilson MA, Bahmed K, Kosmider B. Reactive oxygen species in chronic obstructive pulmonary disease. Oxidative Med Cell Longev. 2018;2018:5730395.

    Article  CAS  Google Scholar 

  6. Capistrano SJ, van Reyk D, Chen H, Oliver BG. Evidence of biomass smoke exposure as a causative factor for the development of COPD. Toxics. 2017;5(4):36.

    Article  PubMed Central  CAS  Google Scholar 

  7. Gellner CA, Reynaga DD, Leslie FM. Cigarette smoke extract: a preclinical model of tobacco dependence. Curr Protocols Neurosci. 2016;77:9.54.51–59.54.10.

    Article  Google Scholar 

  8. Han ZJ, Feng YH, Gu BH, Li YM, Chen H. The post-translational modification, SUMOylation, and cancer (review). Int J Oncol. 2018;52(4):1081–94.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Yang Y, He Y, Wang X, Liang Z, He G, Zhang P, Zhu H, Xu N, Liang S. Protein SUMOylation modification and its associations with disease. Open Biol. 2017;7(10):170167. https://doi.org/10.1098/rsob.170167.

  10. Zhao J. Sumoylation regulates diverse biological processes. Cell Mol Life Sci. 2007;64(23):3017–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Yang P, Hu S, Yang F, Guan X-Q, Wang S-Q, Zhu P, Xiong F, Zhang S, Xu J, Yu Q-L, et al. Sumoylation modulates oxidative stress relevant to the viability and functionality of pancreatic beta cells. Am J Transl Res. 2014;6(4):353–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Lee Y-j, Hallenbeck JM. SUMO and ischemic tolerance. NeuroMolecular Med. 2013;15(4):771–81.

    Article  CAS  PubMed  Google Scholar 

  13. Sarge KD, Park-Sarge O-K. SUMO and its role in human diseases. Int Rev Cell Mol Biol. 2011;288:167–83.

    Article  CAS  PubMed  Google Scholar 

  14. He X, Lai Q, Chen C, Li N, Sun F, Huang W, Zhang S, Yu Q, Yang P, Xiong F, et al. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function. Diabetologia. 2018;61(4):881–95.

    Article  CAS  PubMed  Google Scholar 

  15. Cui W, Zhang Z, Zhang P, Qu J, Zheng C, Mo X, Zhou W, Xu L, Yao H, Gao J. Nrf2 attenuates inflammatory response in COPD/emphysema: crosstalk with Wnt3a/β-catenin and AMPK pathways. J Cell Mol Med. 2018;22(7):3514–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Tatsuta M, Kan OK, Ishii Y, Yamamoto N, Ogawa T, Fukuyama S, Ogawa A, Fujita A, Nakanishi Y, Matsumoto K. Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37. Respir Res. 2019;20(1):251.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Yao Y, Wang Y, Zhang Z, He L, Zhu J, Zhang M, He X, Cheng Z, Ao Q, Cao Y, et al. Chop deficiency protects mice against Bleomycin-induced pulmonary fibrosis by attenuating M2 macrophage production. Mol Ther. 2016;24(5):915–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Li JJ, Tang Q, Li Y, Hu BR, Ming ZY, Fu Q, Qian JQ, Xiang JZ. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid. Acta Pharmacol Sin. 2006;27(8):1078–84.

    Article  CAS  PubMed  Google Scholar 

  19. Kim DY, Abdelwahab MG, Lee SH, O'Neill D, Thompson RJ, Duff HJ, Sullivan PG, Rho JM. Ketones prevent oxidative impairment of hippocampal synaptic integrity through KATP channels. PLoS One. 2015;10(4):e0119316.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Chen L, Miao Z, Xu X. β-Hydroxybutyrate alleviates depressive behaviors in mice possibly by increasing the histone3-lysine9-β-hydroxybutyrylation. Biochem Biophys Res Commun. 2017;490(2):117–22.

    Article  CAS  PubMed  Google Scholar 

  21. Kephart WC, Mumford PW, Mao X, Romero MA, Hyatt HW, Zhang Y, Mobley CB, Quindry JC, Young KC, Beck DT, et al. The 1-week and 8-month effects of a Ketogenic diet or ketone salt supplementation on multi-organ markers of oxidative stress and mitochondrial function in rats. Nutrients. 2017;9(9):1019.

    Article  PubMed Central  CAS  Google Scholar 

  22. Wang X, Wu X, Liu Q, Kong G, Zhou J, Jiang J, Wu X, Huang Z, Su W, Zhu Q. Ketogenic metabolism inhibits histone Deacetylase (HDAC) and reduces oxidative stress after spinal cord injury in rats. Neuroscience. 2017;366:36–43.

    Article  CAS  PubMed  Google Scholar 

  23. Stankovic-Valentin N, Melchior F. Control of SUMO and ubiquitin by ROS: signaling and disease implications. Mol Asp Med. 2018;63:3–17.

    Article  CAS  Google Scholar 

  24. Huang B, Bao J, Cao YR, Gao HF, Jin Y. Cytochrome P450 1A1 (CYP1A1) catalyzes lipid peroxidation of oleic acid-induced HepG2 cells. Biochemistry Biokhimiia. 2018;83(5):595–602.

    Article  CAS  PubMed  Google Scholar 

  25. Hussain T, Al-Attas OS, Al-Daghri NM, Mohammed AA, De Rosas E, Ibrahim S, Vinodson B, Ansari MG, El-Din KIA. Induction of CYP1A1, CYP1A2, CYP1B1, increased oxidative stress and inflammation in the lung and liver tissues of rats exposed to incense smoke. Mol Cell Biochem. 2014;391(1–2):127–36.

    Article  CAS  PubMed  Google Scholar 

  26. Tomanov K, Nukarinen E, Vicente J, Mendiondo GM, Winter N, Nehlin L, Weckwerth W, Holdsworth MJ, Teige M, Bachmair A. Sumoylation and phosphorylation: hidden and overt links. J Exp Bot. 2018;69(19):4583–90.

    Article  CAS  PubMed  Google Scholar 

  27. Zhang Q, Bhattacharya S, Pi J, Clewell RA, Carmichael PL, Andersen ME. Adaptive posttranslational control in cellular stress response pathways and its relationship to toxicity testing and safety assessment. Toxicol Sci. 2015;147(2):302–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Trouw LA, Rispens T, Toes REM. Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis. Nat Rev Rheumatol. 2017;13(6):331–9.

    Article  CAS  PubMed  Google Scholar 

  29. Enserink JM. Sumo and the cellular stress response. Cell Div. 2015;10:4–4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Wei W, Yang P, Pang J, Zhang S, Wang Y, Wang MH, Dong Z, She JX, Wang CY. A stress-dependent SUMO4 sumoylation of its substrate proteins. Biochem Biophys Res Commun. 2008;375(3):454–9.

    Article  CAS  PubMed  Google Scholar 

  31. Princz A, Tavernarakis N. SUMOylation in neurodegenerative diseases. Gerontology. 2020;66(2):122–30. https://doi.org/10.1159/000502142.

  32. Henley JM, Carmichael RE, Wilkinson KA. Extranuclear SUMOylation in neurons. Trends Neurosci. 2018;41(4):198–210.

    Article  CAS  PubMed  Google Scholar 

  33. Zhang J, Chen Z, Zhou Z, Yang P, Wang CY. Sumoylation modulates the susceptibility to type 1 diabetes. Adv Exp Med Biol. 2017;963:299–322.

    Article  CAS  PubMed  Google Scholar 

  34. Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S, Podolsky RH, Muir A, et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet. 2004;36(8):837–41.

    Article  CAS  PubMed  Google Scholar 

  35. Eifler K, Vertegaal ACO. SUMOylation-mediated regulation of cell cycle progression and Cancer. Trends Biochem Sci. 2015;40(12):779–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Seeler JS, Dejean A. SUMO and the robustness of cancer. Nat Rev Cancer. 2017;17(3):184–97.

    Article  CAS  PubMed  Google Scholar 

  37. Wiegman CH, Michaeloudes C, Haji G, Narang P, Clarke CJ, Russell KE, Bao W, Pavlidis S, Barnes PJ, Kanerva J, et al. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2015;136(3):769–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Antus B, Kardos Z. Oxidative stress in COPD: molecular background and clinical monitoring. Curr Med Chem. 2015;22(5):627–50.

    Article  CAS  PubMed  Google Scholar 

  39. Wang DD, Liu Y, Li N, Zhang Y, Jin Q, Hao DC, Piao HL, Dai ZR, Ge GB, Yang L. Induction of CYP1A1 increases gefitinib-induced oxidative stress and apoptosis in A549 cells. Toxicol vitro. 2017;44:36–43.

    Article  CAS  Google Scholar 

  40. Zhou B, Wang X, Li F, Wang Y, Yang L, Zhen X, Tan W. Mitochondrial activity and oxidative stress functions are influenced by the activation of AhR-induced CYP1A1 overexpression in cardiomyocytes. Mol Med Rep. 2017;16(1):174–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Xiu D, Wang Z, Cui L, Jiang J, Yang H, Liu G. Sumoylation of SMAD 4 ameliorates the oxidative stress-induced apoptosis in osteoblasts. Cytokine. 2018;102:173–80.

    Article  CAS  PubMed  Google Scholar 

  42. Pandey D, Chen F, Patel A, Wang CY, Dimitropoulou C, Patel VS, Rudic RD, Stepp DW, Fulton DJ. SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases. Arterioscler Thromb Vasc Biol. 2011;31(7):1634–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Bitto A, Lerner CA, Nacarelli T, Crowe E, Torres C, Sell C. P62/SQSTM1 at the interface of aging, autophagy, and disease. Age (Dordrecht, Netherlands). 2014;36(3):9626.

    Article  CAS  Google Scholar 

  44. Ichimura Y, Komatsu M. Activation of p62/SQSTM1-Keap1-nuclear factor Erythroid 2-related factor 2 pathway in Cancer. Front Oncol. 2018;8:210.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by the Integrated Innovative Team for Major Human Disease Programs of Tongji Medical College, Huazhong University of Science and Technology, and the Innovative Funding for Translational Research from Tongji Hospital. The funders had no role in the study design, data collection and analysis, or writing the manuscript.

Author information

Author notes

  1. Haifeng Zhou and Lei Zhang contributed equally to this work.

Authors and Affiliations

  1. The Center for Biomedical Research, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Caidian, 431000, China

    Haifeng Zhou, Lei Zhang, Yang Li, Guorao Wu, He Zhu, Huilan Zhang, Qing Zhou, Fei Xiong, Qilin Yu, Ping Yang, Shu Zhang & Cong-Yi Wang

  2. Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    Lei Zhang, Guorao Wu, Huilan Zhang & Cong-Yi Wang

  3. The Technology Center, China Tobacco Jiangxi Industrial Co., Ltd., Nanchang High Technology Development Valley, Nanchang, 330096, China

    Jia-Kun Su, Lei Guo & Jibao Cai

Authors
  1. Haifeng Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guorao Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. He Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Huilan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jia-Kun Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Lei Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Qing Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Fei Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Qilin Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Ping Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Shu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Jibao Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Cong-Yi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CYW, LZ and HFZ designed the study. HFZ, LZ and performed the experiments. HFZ, LZ, YL, GRW, HZ and QZ analysed and interpreted the data. HFZ and LZ wrote the manuscript. CYW edited the manuscript. HLZ, JKS, LG, FX, QLY, PY, SZ, JBC and CYW gave the suggestions. All authors reviewed and approved the final version to be published.

Corresponding authors

Correspondence to Jibao Cai or Cong-Yi Wang.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no conflict of interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1: Supplement Fig. 1.

Results for optimized CSE dose and exposure time. (a) Western blot results for SUMO1 expression following different percentage of CSE insult in HBEs. (b) Western blot results for SUMO1 expression following 20% CSE challenge with different time points. The data are represented as the mean ± SEM of 3 independent replications. *, P < 0.05; **, P < 0.01 ***; P < 0.001.

Additional file 2: Supplement Fig. 2.

Apoptosis analysis of SUMO1 or control plasmid transfected HBEs following CSE insult. Annexin V+ 7-AAD− represents early apoptotic HBEs, while Annexin V− 7-AAD+ represents late stage apoptotic HBEs. The data are represented as the mean ± SEM (n = 3). *, P < 0.05; **, P < 0.01 ***; P < 0.001; ****, P < 0.0001.

Additional file 3: Supplement Fig. 3

. CSE insult significantly induces HBEs to undergo apoptosis, which is attenuated by the antioxidant agent Tempol. Annexin V+ 7-AAD− represents early apoptotic HBEs and Annexin V− 7-AAD+ represents late stage apoptotic HBEs. The data are represented as the mean ± SEM (n = 3). *, P < 0.05; **, P < 0.01 ***; P < 0.001; ****, P < 0.0001.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, H., Zhang, L., Li, Y. et al. Cigarette smoke extract stimulates bronchial epithelial cells to undergo a SUMOylation turnover. BMC Pulm Med 20, 276 (2020). https://doi.org/10.1186/s12890-020-01300-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12890-020-01300-w

Keywords

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us